[Translation] An open-label, randomized, controlled, multicenter phase III clinical study evaluating the efficacy and safety of tolacitinib capsules versus investigator's choice combination chemotherapy in patients with NRAS-mutated advanced melanoma who have previously received immunotherapy
评价妥拉美替尼胶囊对比研究者选择的联合化疗在既往接受过免疫治疗的NRAS突变的晚期黑色素瘤患者中的无进展生存期(PFS)
[Translation] To evaluate progression-free survival (PFS) of tolacitinib capsules versus investigator's choice of combination chemotherapy in patients with NRAS-mutated advanced melanoma who have previously received immunotherapy